After seeing a double top in January, CLOV seems to have found its lowest level of support around $6.28 per share. Analysts have a price target around $13-$15 per share, which is very reasonable based on Fib retracement. Furthermore, on the daily chart, we see the MACD converging back up toward the signal, with the RSI 14 back on the rise now, from bottoming out at about 26.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.